Data from Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination Immunotherapy
Authors:
- Gabriela MarsavelaGMGabriela Marsavela
- Jenny LeeJLJenny Lee
- Leslie CalapreLCLeslie Calapre
- Stephen Q. WongSWStephen Q. Wong
- Michelle R. PereiraMPMichelle R. Pereira
- Ashleigh C. McEvoyAMAshleigh C. McEvoy
- Anna L. ReidARAnna L. Reid
- Cleo RobinsonCRCleo Robinson
- Lydia WarburtonLWLydia Warburton
- Afaf AbedAAAfaf Abed
- Muhammad A. KhattakMKMuhammad A. Khattak
- Tarek M. MeniawyTMTarek M. Meniawy
Open Access
- 31 March 2023
- other
- Published by American Association for Cancer Research (AACR)